NeuroPn Therapeutics is a biopharmaceutical company focused on the discovery and development of innovative and safer drugs or drug combinations for neurodegenerative diseases with focus on acute and chronic pain and Parkinson's disease.  

Discovery strategy - NeuroPn has studied biochemical pathways and identified novel therapies to address gaps in safety and efficacy of marketed drugs. Key features of NeuroPn’s discovery strategy include


  • Discriminatory Product Profile – Our focus is to discover and develop novel medicines that address unmet needs in acute and chronic pain. We aim to provide safer and more efficacious therapeutics for patients-in-need

  • Leveraging Global Networks – We maximize our investments utilizing efficient, cost-effective structure and collaboration with high quality CROs across the globe

  • Strategic Partnerships - Our business strategy is to build risk shared partnerships to identify clinical candidates and establish early proof of concept